ABC | Volume 113, Nº1, July 2019

Statement Statement on Antiplatelet Agents and Anticoagulants in Cardiology – 2019 Arq Bras Cardiol. 2019; 113(1):111-134 Statement on Antiplatelet Agents and Anticoagulants in Cardiology – 2019 Development: The Department of Clinical Cardiology of the Brazilian Society of Cardiology (Departamento de Cardiologia Clínica da Sociedade Brasileira da Cardiologia) Norms and Guidelines Council: Fernando Bacal, Leandro Ioschpe Zimerman, Paulo Ricardo Avancini Caramori e Pedro A. Lemos Norms and Guidelines Coordinator: Ludhmila Abrahão Hajjar President of the Department of Clinical Cardiology: João Luiz Fernandes Petriz Statement Coordinator: Carlos V. Serrano Jr. Statement Authors: Carlos V. Serrano Jr., 1,2, 3 A lexandre de M. Soeiro, 1,3 Tatiana C. A. Torres Leal, 1 Lucas C. Godoy, 1 Bruno Biselli, 1 Luiz Akira Hata, 1 Eduardo B. Martins, 1 Isabela C. K. Abud-Manta, 1,2 Caio A. M. Tavares, 1 Francisco Akira Malta Cardozo, 1,3 Múcio Tavares de Oliveira Jr. 1 Instituto do Coração do Hospital das Clínicas da Universidade de São Paulo, 1 São Paulo, SP – Brazil Hospital Israelita Albert Einstein, 2 São Paulo, SP – Brazil Hospital Beneficência Portuguesa Mirante, 3 São Paulo, SP – Brazil This statement shall be referred to as: Serrano Jr. CV, Soeiro AM, Leal TCAT, Godoy LC, Biselli B, Hata LA et al. Statement on Antiplatelet Agents and Anticoagulants in Cardiology – 2019. Arq Bras Cardiol. 2019; 113(1):111-134. Note: These Guidelines are for information purposes and are not to replace the clinical judgment of a physician, who must ultimately determine the appropriate treatment for each patient. Correspondence: Sociedade Brasileira de Cardiologia - Av. Marechal Câmara, 360/330 - Centro - Rio de Janeiro – Postal Code: 20020-907. E-mail: sbc@cardiol.br . DOI: 10.5935/abc.20190128 111